SK91694A3 - Spray-cooled nabumetone, method of its preparation and use - Google Patents

Spray-cooled nabumetone, method of its preparation and use Download PDF

Info

Publication number
SK91694A3
SK91694A3 SK916-94A SK91694A SK91694A3 SK 91694 A3 SK91694 A3 SK 91694A3 SK 91694 A SK91694 A SK 91694A SK 91694 A3 SK91694 A3 SK 91694A3
Authority
SK
Slovakia
Prior art keywords
nabumetone
spray
cooled
tablet
dosage form
Prior art date
Application number
SK916-94A
Other languages
English (en)
Slovak (sk)
Inventor
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK91694A3 publication Critical patent/SK91694A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coating By Spraying Or Casting (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Catching Or Destruction (AREA)
  • Road Signs Or Road Markings (AREA)
  • Freezing, Cooling And Drying Of Foods (AREA)
SK916-94A 1992-01-29 1993-01-22 Spray-cooled nabumetone, method of its preparation and use SK91694A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929201857A GB9201857D0 (en) 1992-01-29 1992-01-29 Novel compound
PCT/GB1993/000145 WO1993014747A1 (en) 1992-01-29 1993-01-22 Spray-chilled nabumetone

Publications (1)

Publication Number Publication Date
SK91694A3 true SK91694A3 (en) 1995-03-08

Family

ID=10709436

Family Applications (1)

Application Number Title Priority Date Filing Date
SK916-94A SK91694A3 (en) 1992-01-29 1993-01-22 Spray-cooled nabumetone, method of its preparation and use

Country Status (24)

Country Link
US (1) US5539000A (de)
EP (1) EP0624087B1 (de)
JP (1) JPH07503245A (de)
KR (1) KR950700056A (de)
CN (1) CN1079954A (de)
AT (1) ATE150298T1 (de)
AU (1) AU3362693A (de)
BG (1) BG98933A (de)
BR (1) BR9305674A (de)
CA (1) CA2129027A1 (de)
CZ (1) CZ182894A3 (de)
DE (1) DE69309037T2 (de)
DK (1) DK0624087T3 (de)
ES (1) ES2099419T3 (de)
FI (1) FI943550A7 (de)
GB (1) GB9201857D0 (de)
GR (1) GR3023142T3 (de)
HU (1) HUT67462A (de)
IL (1) IL104526A0 (de)
MX (1) MX9300430A (de)
NO (1) NO942813L (de)
SK (1) SK91694A3 (de)
WO (1) WO1993014747A1 (de)
ZA (1) ZA93577B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB9920148D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel composition
US6552078B2 (en) 1999-10-27 2003-04-22 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
TWI262791B (en) 1999-10-27 2006-10-01 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US6436990B1 (en) 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
US20020132010A1 (en) * 2000-12-22 2002-09-19 Yihong Qui Divalproex sodium dosage forms and a process for their production
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
JP2007513143A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 押出機を使用して好ましくはポロクサマーおよびグリセリドを含む多粒子アジスロマイシン組成物を製造するための噴霧凝固法
JP2007513139A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 安定性の改善した多粒子組成物
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
CA2549225A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2547239A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Azithromycin multiparticulate dosage forms by liquid-based processes
JP2007513145A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法
AU2005295609A1 (en) * 2004-10-15 2006-04-27 Spectrum Pharmaceuticals, Inc. Phosphate binder with reduced pill burden
JP2009504779A (ja) * 2005-08-17 2009-02-05 アルテアナノ インコーポレイテッド 家畜における慢性腎不全及びその他の病気の治療：組成物及び方法
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US7541384B2 (en) * 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
KR101940207B1 (ko) 2010-05-12 2019-01-18 스펙트럼 파마슈티컬즈 인크 란탄 카보네이트 하이드록사이드, 란탄 옥시카보네이트 및 이들의 제조 및 사용 방법
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy
US12150945B2 (en) 2018-07-20 2024-11-26 Lipocine Inc. Liver disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474377A (en) 1973-09-11 1977-05-25 Beecham Group Ltd Naphthalene derivatives
US4420639C1 (en) * 1973-09-11 2001-08-21 Beecham Group Ltd Aromatic compounds
US4086346A (en) 1974-04-06 1978-04-25 Bayer Aktiengesellschaft Preparation of melt-sprayed spherical phenacetin granules
DE3833446A1 (de) * 1988-10-01 1990-04-05 Hoechst Ag Verfahren zur herstellung von arzneimittelwirkstoff-partikeln mit verbesserten fliess-, lager- und formulierungseigenschaften sowie arzneimittel, die diese arzneimittelwirkstoff-partikeln enthalten

Also Published As

Publication number Publication date
GR3023142T3 (en) 1997-07-30
EP0624087B1 (de) 1997-03-19
MX9300430A (es) 1994-08-31
HUT67462A (en) 1995-04-28
DK0624087T3 (da) 1997-09-01
WO1993014747A1 (en) 1993-08-05
KR950700056A (ko) 1995-01-16
BG98933A (en) 1995-07-28
FI943550A0 (fi) 1994-07-28
JPH07503245A (ja) 1995-04-06
ATE150298T1 (de) 1997-04-15
FI943550L (fi) 1994-07-28
GB9201857D0 (en) 1992-03-18
ZA93577B (en) 1994-01-13
CN1079954A (zh) 1993-12-29
HU9402221D0 (en) 1994-09-28
DE69309037T2 (de) 1997-07-24
DE69309037D1 (de) 1997-04-24
FI943550A7 (fi) 1994-07-28
ES2099419T3 (es) 1997-05-16
NO942813D0 (no) 1994-07-28
CZ182894A3 (en) 1995-02-15
EP0624087A1 (de) 1994-11-17
NO942813L (no) 1994-07-28
BR9305674A (pt) 2005-01-11
US5539000A (en) 1996-07-23
AU3362693A (en) 1993-09-01
IL104526A0 (en) 1993-05-13
CA2129027A1 (en) 1993-08-05

Similar Documents

Publication Publication Date Title
EP0624087B1 (de) Sprüherstarrtes nabumeton
JP3589977B2 (ja) 活性成分としてクロドロン酸塩および賦形剤としてケイ化微晶質セルロースを含む医薬製剤
CN113438944A (zh) 一种parp抑制剂微丸制剂及其制备工艺
US4632843A (en) Process for the preparation of solid pharmaceutical products
MXPA01011071A (es) Composicion farmaceutica en forma unitaria que contiene acido acetilsalicilico e hidrogenosulfato de clopidogrel.
SK8022002A3 (en) Compressed tablet composition, process for the preparation thereof and its use
JP2006528221A (ja) ビカルタミドの形態、組成物、およびその製造方法
JP3180359B2 (ja) 錠剤様発泡性農薬組成物の製造法
CZ303694B6 (cs) Prípravek nesteroidního protizánetlivého léciva obsahující granulární a extragranulární kompozici a zpusob jeho prípravy
CN105106152A (zh) 一种盐酸决奈达隆组合物
JPH0691150A (ja) マスクされた粒状物
KR100358614B1 (ko) 푸시드산정제의제조방법
EP3288535B1 (de) Monensin-wasser-dispergierbare granulate durch nassgranulation
EP2946771B1 (de) Wasserdispergierbare tablettenformulierung mit deferasirox
US4795646A (en) Process for the preparation of binder-free, tablettable granules of celiprolol hydrochloride
EP1292598A1 (de) Verfahren zur trocknung von amoxicillin
EP2526931B1 (de) Nasse Granulationsmethoden für Cetylmyristat und/oder Cetylpalmitat
SI9300045A (sl) Prsilno ohlajen nabumeton in postopek za njegovo izdelavo
KR100455797B1 (ko) 미립상 형태의 테트라히드로피리딘 유도체
EP3782621A1 (de) Pharmazeutische zubereitung mit sofortiger freisetzung eines gerinnungshemmers und verfahren zu ihrer herstellung
NZ207514A (en) Preparing solid state dispersions of chlorthalidone(2-chloro-5-(1-hydroxy-3-oxo-isoindolinyl)-benzenesulphonamide)
EP2682104A1 (de) Sich im Mund auflösende Formulierungen aus Dexketoprofen
EP0362731A2 (de) Verfahren zur Herstellung von Arzneimittelwirkstoff-Partikeln mit verbesserten Fliess-, Lager- und Formulierungseigenschaften sowie Arzneimittel, die diese Arzneimittelwirkstoff-Partikeln enthalten
HK40076540A (en) Parp inhibitor pellet preparation and preparation process therefor
JPH01301620A (ja) カルバミン酸クロルフェネシン含有粒状物およびその製法